Drug Topics
APRIL 24, 2023
The Senate Finance Committee recently released a framework for legislation, and the leaders of the “big three” PBMs are scheduled to be witnesses at another committee's hearing regarding insulin prices on May 10.
PhRMA
APRIL 24, 2023
If we needed any more proof that the health insurance and pharmacy benefit manager (PBM) industries are one and the same, look no further than a new ad campaign by America’s Health Insurance Plans (AHIP). With PBMs facing increasing scrutiny on Capitol Hill, AHIP is hitting the airwaves to deflect any responsibility for the high cost of medicine many people face.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 24, 2023
Post-COVID-19 conditions were more common in unvaccinated children than in children who had received at least 1 dose of a COVID-19 vaccine.
PhRMA
APRIL 24, 2023
Nonprofit hospitals are supposed to help provide access to crucial treatment and services in our most vulnerable communities. But recent research adds to the mountain of evidence showing nonprofit hospitals continue to fall short in their community benefit. For example, many nonprofit hospitals participate in the federal 340B Drug Pricing Program, where eligible large nonprofit hospitals can buy deeply discounted 340B medicines and then turn around and charge both uninsured patients and insuranc
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 24, 2023
Combining the two drugs appears more likely to reduce risk of early COVID-19 symptoms worsening than taking either one on its own.
PharmaVoice
APRIL 24, 2023
Dr. Preeti Parikh sees parallels between promoting health equity and current DE&I challenges in the workplace.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
APRIL 24, 2023
Two decades after the Human Genome Project, scientists are on the brink of uncovering its full potential for drug development.
Fierce Healthcare
APRIL 24, 2023
Home care industry touts bipartisan bill to expand Medicare in-home benefits, reimbursement dmuoio Mon, 04/24/2023 - 14:08
PharmaVoice
APRIL 24, 2023
Tuberculosis control and funding lost 20 years of progress during the COVID-19 pandemic, but scientists and world health groups are still plugging away.
Pharmacy Times
APRIL 24, 2023
Lowering blood pressure could be dangerous for people with normal blood pressure.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
APRIL 24, 2023
As generative AI makes headway in healthcare, executive leaders still struggle to scale up breakthrough tech aburky Mon, 04/24/2023 - 13:23
Pharmacy Times
APRIL 24, 2023
The results of a review, published in Cureus, show that the medications reduced the risk of HF.
Drug Store News
APRIL 24, 2023
Attendees got the chance to connect with new and existing business partners and enjoy a wide assortment of cuisine.
Pharmacy Times
APRIL 24, 2023
Efficacy and safety data for BeiGene’s therapy shows positive results for individuals with advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
APRIL 24, 2023
AppliedVR's latest partnership expands covered access to VR therapeutics for veterans, active military hlandi Mon, 04/24/2023 - 10:46
Pharmacy Times
APRIL 24, 2023
Infusion reactions in the switching group did not occur with switching, but rather only with reference trastuzumab administration.
European Pharmaceutical Review
APRIL 24, 2023
Included in this issue of European Pharmaceutical Review : FOREWORD New quality requirements for tobacco products David Elder, David P Elder Consultancy QA/QC MASS SPECTROMETRY The benefits of mass spectrometry for expediting biologics to patients Ian Anderson, Mostafa Zarei and Qifeng Zhang, Lonza IN-DEPTH FOCUS: Bioprocessing/Bioproduction Realising the potential of AAV gene therapies Rajiv Vaidya, Andelyn Biosciences What gene therapy manufacturers can gain from collaboration Neil Almstead,
Pharmacy Times
APRIL 24, 2023
A 10% increase in the proportion of adults aged 50 years or older was associated with a 1.2% increase in pneumococcal vaccination coverage.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
APRIL 24, 2023
Apellis hits setback in ALS trial after pair of pegcetacoplan approvals fkansteiner Mon, 04/24/2023 - 10:56
Pharmacy Times
APRIL 24, 2023
Choosing the best biosimilar based on reimbursement can be challenging.
European Pharmaceutical Review
APRIL 24, 2023
Included in this Guide to Testing: Exploring low endotoxin recovery in drug products Chiara Celli, Marco Mingolla and Fabrizio Lecce from the Institute of Biomedical Research Antoine Marxer, discuss low endotoxin recovery in drug products analysed using the monocyte activation test. Sustainability in BET from your endotoxin experts Associates of Cape Cod International, Inc. explores the future of sustainable LAL testing.
Pharmacy Times
APRIL 24, 2023
The crucial role of self-care pharmacy practice requires that pharmacists develop a robust understanding of the implications of the current and proposed regulatory changes for nonprescription drugs.
Fierce Healthcare
APRIL 24, 2023
AHIP ad campaign: Big Pharma continues 'deceive and divert attention' on drug prices pminemyer Mon, 04/24/2023 - 12:12
European Pharmaceutical Review
APRIL 24, 2023
Realising the potential of AAV gene therapies Dr Rajiv Vaidya, Head of Manufacturing Science & Technology at Andelyn Biosciences, explores strategies for improving the scalability and cost‑effectiveness of AAV production while maintaining regulatory compliance. What gene therapy manufacturers can gain from collaboration Neil Almstead, Chief Technical Operations Officer at PTC Therapeutics, shares his view on why collaboration is key to streamlining manufacture of gene therapies.
Drug Store News
APRIL 24, 2023
The acquisition is designed to enable the company to sustain strong growth for its SkinnyPop brand.
Pharmaceutical Technology
APRIL 24, 2023
The National Institute for Health and Care Excellence (NICE) has published a final draft guidance recommending the use of Darzalex (daratumumab) with bortezomib and dexamethasone (DVd) for adults with previously treated multiple myeloma. The draft guidance is open for feedback from consultees after which the document and its recommendations will be used to establish the organization’s guidance on the use of this combination regimen for patients in the UK’s National Health Services.
Drug Store News
APRIL 24, 2023
The report highlights BJ’s environmental, social and governance objectives and progress.
PharmExec
APRIL 24, 2023
Cost Plus Drug Co. adds J&J's Janssen medications to its offerings, increasing affordability for diabetes patients.
The Honest Apothecary
APRIL 24, 2023
Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. I might throw in a something off-topic from time to time which I found while wandering throughout the endless hallways and corridors of the internet. All article shared will be free to read and not locked behind an annoying paywall.
European Pharmaceutical Review
APRIL 24, 2023
Positive results from the long-term follow-up of a Phase II study of small molecule inhibitor UBX1325 in patients with diabetic macular edema (DME) have been announced. “UBX1325 achieved visual improvement with a single injection, and maintained this improvement in over 50 percent of patients for a year,” noted Dr Jeffrey S Heier, Director of Retina Research at Ophthalmic Consultants of Boston.
Drug Store News
APRIL 24, 2023
The Appeals Court affirmed the validity of the patent expiring in 2028.
European Pharmaceutical Review
APRIL 24, 2023
Yescarta ® (axicabtagene ciloleucel or axi-cel) has achieved a median European commercial manufacturing turnaround time of 19 days for patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). New European analysis of the CAR T-cell therapy showing these results were presented at the 2023 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT).
Drug Store News
APRIL 24, 2023
Placer.ai reports that following a strong January, retail traffic slowed somewhat as consumers continued adjusting their spending habits to inflationary prices.
Expert insights. Personalized for you.
469 
Let's personalize your content